Rosso-Fernández, C. M., Retamar, P., Gutiérrez-Gutiérrez, B., Pascual, A., Salamanca, E., Merino, V., . . . Camean-Fernández, M. (2021). Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): Protocol for a randomised, pragmatic trial. BMJ Publishing Group.
Cita Chicago Style (17a ed.)Rosso-Fernández, Clara M., et al. Temocillin Versus Meropenem for the Targeted Treatment of Bacteraemia Due to Third-generation Cephalosporin-resistant Enterobacterales (ASTARTÉ): Protocol for a Randomised, Pragmatic Trial. BMJ Publishing Group, 2021.
Cita MLA (8a ed.)Rosso-Fernández, Clara M., et al. Temocillin Versus Meropenem for the Targeted Treatment of Bacteraemia Due to Third-generation Cephalosporin-resistant Enterobacterales (ASTARTÉ): Protocol for a Randomised, Pragmatic Trial. BMJ Publishing Group, 2021.